cjc-1295 & ipamorelin blend + – Growth Hormone 99%+ Pure tesamorelin cjc 1295 ipamorelin blend

These cellular dynamics mirror physiological growth hormone secretion patterns observed during endogenous GHRH stimulation, suggesting that Ipamorelin activates conserved secretory mechanisms rather than inducing non-physiological release patterns

Clinical studies confirmed that the peptide produces no changes in serum IGF-1 levels, eliminating the appetite-stimulating effects associated with growth hormone therapy

Most IGF-1 LR3 vials come in a 1mg (or 1000mcg) size

The blend offers several advantages over synthetic growth hormone: More natural pulsatile release Lower cost Fewer side effects Legal status (for research purposes) Maintains natural feedback mechanisms However, synthetic GH produces more dramatic results at higher doses

A follow-up study in mice revealed that the mechanism of PrxV in achieving this role appears to be through phosphorylation of AMPK pathway (Kim et al., 2020)

Avoid Desensitization Use lower to moderate doses (4080 mcg/day) to minimize the risk of diminishing returns